Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.
Latest Information Update: 15 May 2023
At a glance
- Drugs Enoxaparin sodium (Primary) ; Heparin (Primary)
- Indications Deep vein thrombosis; Thromboembolism
- Focus Therapeutic Use
- 09 May 2023 Status changed from active, no longer recruiting to completed.
- 24 Oct 2022 Planned End Date changed from 30 Mar 2022 to 31 Dec 2022.
- 24 Oct 2022 Status changed from recruiting to active, no longer recruiting.